BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37970452)

  • 1. Demographics and Clinical Characteristics of Patients with Neurocysticercosis: A Retrospective Study from Dali, China.
    Zhu HX; Li YC; Yang XP; Chu YH; Guo W; Chen RX; Guo DD; Cheng LJ; Li Y
    Saudi J Med Med Sci; 2023; 11(4):283-291. PubMed ID: 37970452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From seizures to epilepsy and its substrates: neurocysticercosis.
    Singh G; Burneo JG; Sander JW
    Epilepsia; 2013 May; 54(5):783-92. PubMed ID: 23621876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcified Neurocysticercosis: Demographic, Clinical, and Radiological Characteristics of a Large Hospital-Based Patient Cohort.
    Bustos JA; Arroyo G; Del Brutto OH; Gonzales I; Saavedra H; Guzman C; Sanchez-Boluarte SS; Thakur KT; Coyle C; O'Neal SE; Garcia HH;
    Pathogens; 2023 Dec; 13(1):. PubMed ID: 38251334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation of neurocysticercosis-related epilepsy.
    Duque KR; Burneo JG
    Epilepsy Behav; 2017 Nov; 76():151-157. PubMed ID: 28882721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epilepsy Due to Solitary Calcified Cysticercus Granuloma.
    Murthy JMK
    Pathogens; 2023 Aug; 12(8):. PubMed ID: 37623997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of three patients with extensive neurocysticercosis in rural southern Tanzania: neurological, serological and neuroradiological findings.
    Stelzle D; Makasi C; Welte TM; Ruether C; Schmidt V; Gabriel S; Bottieau E; Fleury A; Ngowi BJ; Winkler AS;
    J Med Case Rep; 2023 Jul; 17(1):311. PubMed ID: 37408061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocysticercosis: new thoughts on controversial issues.
    Del Brutto OH
    Curr Opin Neurol; 2013 Jun; 26(3):289-94. PubMed ID: 23493161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocysticercosis in non-endemic regions: The experience of Qatar.
    Haddad N; Shaheen Y; Abunaib M; Melikyan G; El Sotouhy A; Wahbeh F; Nauman A; Al-Maadid F; Soliman M; Mesraoua B; Elkhider H; Mahfoud Z
    Front Neurol; 2023; 14():1173909. PubMed ID: 37153684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocysticercosis.
    Garcia HH
    Neurol Clin; 2018 Nov; 36(4):851-864. PubMed ID: 30366559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the association of neurocysticercosis and mesial temporal lobe epilepsy and its impact on the surgical treatment of patients with drug-resistant epilepsy.
    Bianchin MM; Velasco TR; Wichert-Ana L; Dos Santos AC; Sakamoto AC
    Epilepsy Behav; 2017 Nov; 76():168-177. PubMed ID: 28462844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racemose neurocysticercosis.
    Krupa K; Krupa K; Pisculli ML; Athas DM; Farrell CJ
    Surg Neurol Int; 2016; 7():12. PubMed ID: 26958418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocysticercosis: the enigmatic disease.
    Agapejev S
    Cent Nerv Syst Agents Med Chem; 2011 Dec; 11(4):261-84. PubMed ID: 22300228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of serological testing for the diagnosis of prevalent neurocysticercosis in outpatients with epilepsy, Eastern Cape Province, South Africa.
    Foyaca-Sibat H; Cowan LD; Carabin H; Targonska I; Anwary MA; Serrano-OcaƱa G; Krecek RC; Willingham AL
    PLoS Negl Trop Dis; 2009 Dec; 3(12):e562. PubMed ID: 19997629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional study of people with epilepsy and neurocysticercosis in Tanzania: clinical characteristics and diagnostic approaches.
    Blocher J; Schmutzhard E; Wilkins PP; Gupton PN; Schaffert M; Auer H; Gotwald T; Matuja W; Winkler AS
    PLoS Negl Trop Dis; 2011 Jun; 5(6):e1185. PubMed ID: 21666796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects of neurocysticercosis.
    Takayanagui OM; Odashima NS
    Parasitol Int; 2006; 55 Suppl():S111-5. PubMed ID: 16330240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocysticercosis.
    Singhi P
    Ther Adv Neurol Disord; 2011 Mar; 4(2):67-81. PubMed ID: 21694805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the clinico radiological heterogeneity and the immune-inflammatory profiles in pediatric patients with neurocysticercosis from a tertiary referral centre.
    Kashyap B; Das S; Jain S; Agarwal A; Kaushik JS; Kaur IR
    J Trop Pediatr; 2012 Aug; 58(4):320-3. PubMed ID: 22123942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocysticercosis-related seizures: Imaging biomarkers.
    Ratcliffe C; Adan G; Marson A; Solomon T; Saini J; Sinha S; Keller SS
    Seizure; 2023 May; 108():13-23. PubMed ID: 37060627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of people with epilepsy and Neurocysticercosis in three eastern African countries-A pooled analysis.
    Stelzle D; Schmidt V; Keller L; Ngowi BJ; Matuja W; Escheu G; Hauke P; Richter V; Ovuga E; Pfausler B; Schmutzhard E; Amos A; Harrison W; Kaducu J; Winkler AS
    PLoS Negl Trop Dis; 2022 Nov; 16(11):e0010870. PubMed ID: 36342903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocysticercosis as an infectious acquired epilepsy worldwide.
    Reddy DS; Volkmer R
    Seizure; 2017 Nov; 52():176-181. PubMed ID: 29055271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.